NEWS

Sanofi says application for new diabetes drug under FDA review

Tuesday, Sep 29, 2015

European pharmaceuticals group Sanofi on Tuesday said its application for review for its new drug, lixisenatide, a diabetes treatment, had been accepted by the U.S. Food and Drug Administration.

 

reuters.com

Other News